Gabrielle Rabu
Overview
Explore the profile of Gabrielle Rabu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashi K, Rabu G, Cui Z, Klaire S, Homayra F, Milloy M, et al.
Subst Use Addctn J
. 2024 May;
45(4):653-663.
PMID: 38804580
Background: For structurally marginalized populations, including people who use drugs (PWUD), equitable access to healthcare can be achieved through healthcare access supports. However, few studies characterized utilization of formal (eg,...
2.
Miller P, Rabu G, MacAldaz M, Knapp D, Cheung A, Dhillon K, et al.
Exp Hematol
. 2017 Jan;
48:41-49.
PMID: 28087429
Xenograft models are transforming our understanding of the output capabilities of primitive human hematopoietic cells in vivo. However, many variables that affect posttransplantation reconstitution dynamics remain poorly understood. Here, we...
3.
Miller P, Nakamichi N, Knapp D, Rabu G, Schultz K, Jones D, et al.
Biol Blood Marrow Transplant
. 2016 Aug;
22(11):1945-1952.
PMID: 27496214
Plerixafor (P) together with granulocyte colony-stimulating factor (G) is now recognized as an important strategy for mobilizing hematopoietic cells for use in patients given myelosuppressive therapies. However, quantitative comparisons of...
4.
Miller P, Knapp D, Beer P, MacAldaz M, Rabu G, Cheung A, et al.
Exp Hematol
. 2016 Apr;
44(7):635-40.
PMID: 27090409
The critical human cells that produce neutrophils and platelets within 3 weeks in recipients of hematopoietic transplants are thought to produce these mature blood cells with the same kinetics in...
5.
Beer P, Knapp D, Kannan N, Miller P, Babovic S, Bulaeva E, et al.
Stem Cell Reports
. 2014 Nov;
3(5):841-57.
PMID: 25418728
Disrupted IKAROS activity is a recurrent feature of some human leukemias, but effects on normal human hematopoietic cells are largely unknown. Here, we used lentivirally mediated expression of a dominant-negative...
6.
Beer P, Knapp D, Miller P, Kannan N, Sloma I, Heel K, et al.
Blood
. 2014 Nov;
125(3):504-15.
PMID: 25370416
Without effective therapy, chronic-phase chronic myeloid leukemia (CP-CML) evolves into an acute leukemia (blast crisis [BC]) that displays either myeloid or B-lymphoid characteristics. This transition is often preceded by a...
7.
Miller P, Cheung A, Beer P, Knapp D, Dhillon K, Rabu G, et al.
Blood
. 2012 Dec;
121(5):e1-4.
PMID: 23233660
Unlabelled: Better methods to characterize normal human hematopoietic cells with short-term repopulating activity cells (STRCs) are needed to facilitate improving recovery rates in transplanted patients.We now show that 5-fold more...